Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Prostate Drug Offers Relief for Kidney Stone Sufferers

By Emergency Medicine Foundation Australasia | November 2, 2016

Millions of Australians suffering from kidney stones could soon get relief, with researchers discovering a prostrate treatment can also help ease the painful condition.

Patients with kidney stones were treated with the drug Tamsulosin in an Emergency Medicine Foundation Australasia (EMF) funded clinical trial run across five Australian hospital emergency departments.

Trial leader and specialist emergency medicine physician at The Townsville Hospital, Dr. Jeremy Furyk, said Tamsulosin was normally used to treat an enlarged prostate, but the research team found the treatment could also assist the passage of large kidney stones in the urine.

“Kidney stones are a bit of a mystery, occur frequently in the community and generally affect young, healthy adults,” Dr. Furyk said.

“It can be extremely painful to pass these jagged little crystallized minerals and it’s very common for sufferers to go to an emergency department for treatment. 

“Of more than 400 patients in the trial, we found those who received Tamsulosin passed their large kidney stones more often than the placebo group. 

“This means patients with large stones might not need more complicated treatments including surgeries, and this has potential to improve care and reduce costs. We’re very excited because Tamsulosin treatment may also allow patients to be treated closer to home rather than needing referral to a major center.”

EMF Australasia awarded more than $270,000 to support Dr Furyk’s research, through its Queensland Research Program, which is funded by the Queensland Government Department of Health. 

EMF Australasia chair, associate professor Sally McCarthy said this research had the potential to help millions of Australians suffering with this extremely painful condition. 

“It may also have implications for patients living in rural and regional areas, where access to urologists — the specialist doctors who treat this condition — can be limited.”

Up to 15 per cent of the Australian adult population and one in 11 people in the United States suffer from kidney stones, which range in size from a grain of sand to a pearl or even larger, and can be excruciating to pass through the urinary tract.

Dr. Furyk’s research was recently published in the Annals of Emergency Medicine.

EMF is an Australasian non-profit organization that funds evidence-based emergency medicine research that will improve clinical practices. The foundation was established in 2007 with the support of the Queensland government. https://www.emergencyfoundation.org.au.

(Source: EurekAlert!)


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50